Skip to main content
SpringerLink
Log in

Colorectal cancer screening and quality of life

  • Research Papers
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

To evaluate the quality of life of patients following surgery for colorectal cancer, and to compare the quality of life between patients whose cancer was detected as a result of faecal occult blood screening with that of patients whose cancer presented symptomatically, an analysis was conducted within the context of the randomized controlled trial of colorectal cancer screening, University Hospital, Nottingham, UK. A total of 418 survivors of the trial's test and control groups and 33 randomly selected cancer patients completed quality of life questionnaires (Nottingham Health Profile and Health Measurement Questionnaire). The mode of entry to diagnosis and treatment (screening vs. non-screening) appeared to exert no major impact on post-intervention quality of life. The stage of cancer progression was not closely related to outcome life quality. A quality of life coefficient for surviving patients based on the Rosser classification was estimated to lie within the range 0.948–0.981. This figure accords well with the estimates of other studies of interventions in populations of similar age. Overall, there are no grounds for belleving that faecal occult blood screening for colorectal cancer per se significantly influences patients' post-intervention quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kronborg O, Fenger C, Olsen J. et al. Repeated screening for colorectal cancer with faecal occult blood test. Scand J Gastroenterol 1989; 24: 599–606.

    Google Scholar 

  2. Kewenter J, Bjork S, Haglind E, et al. Screening and rescreening for colorectal cancer. Cancer 1988; 62: 645–651.

    Google Scholar 

  3. Faivre J, Arveux P, Milan C, et al. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev 1991; 1: 49–55.

    Google Scholar 

  4. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised controlled trial of faecal occult blood screening for colorectal cancer: results for the first 107,344 patients. Lancet 1989; i: 1160–1164.

    Google Scholar 

  5. Tuck J, Walker AR, Whynes DK, et al. Screening and the costs of treating colorectal cancer: some preliminary results. Publ Health 1989; 103: 413–419.

    Google Scholar 

  6. Walker AR, Whynes DK, Chamberlain JO, et al. The costs of screening for colorectal cancer. J Epidemiol Commun Health 1991; 45: 220–224.

    Google Scholar 

  7. Walker AR, Whynes DK, Hardcastle JD, et al. The hospital costs of diagnostic procedures for colorectal cancer. J Clin Epidemiol 1991; 44: 907–914.

    Google Scholar 

  8. Whynes DK, Walker AR, Hardcastle JD. Cost-effective screening strategies for colorectal cancer. J Publ Health Med 1992; 14: 43–49.

    Google Scholar 

  9. Whynes DK, Walker AR, Chamberlain JO, et al. Screening and the costs of treating colorectal cancer. Br J Cancer 1993; 68: 965–968.

    Google Scholar 

  10. Williams NS, Johnston D. The quality of life after rectal excision for low rectal cancer. Br J Surg 1983; 70: 460–462.

    Google Scholar 

  11. Turnbull RB, Kyle K, Watson FR, et al. Cancer of the colon: the influence of the no touch isolation technique on survival rates. Ann Surg 1967; 166: 420–427.

    Google Scholar 

  12. Schag CAC, Heinrich RL. Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990; 4: 135–138.

    Google Scholar 

  13. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organisation for Research and Treatment of Cancer QLQ-30: a quality-of-life instrument for use in international clinical trials in oncology. J Int Cancer Inst 1993; 85: 365–376.

    Google Scholar 

  14. Clark A, Fallowfield LJ. Quality of life measurements in patients with malignant disease: a review. J Roy Soc Med 1986; 79: 165–169.

    Google Scholar 

  15. Maguire P, Selby P. Assessing quality of life in cancer patients. Br J Cancer 1989; 60: 437–440.

    Google Scholar 

  16. Williams A. Economics of coronary artery bypass grafting. Br Med J 1985; 291: 326–329.

    Google Scholar 

  17. Rosser RM, Watts VC. The measurement of hospital output. Int J Epidemiol 1972; 1: 361–368.

    Google Scholar 

  18. Rosser RM, Kind P. A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol 1978; 7: 347–358.

    Google Scholar 

  19. Kind P, Rosser RM, Williams A. Valuation of quality of life: some psychometric evidence. In: Jones-Lee MW, ed. The Value of Life and Safety. Geneva: North-Holland, 1982: 159–170.

    Google Scholar 

  20. Jennett B, Buxton M. When is treatment for cancer economically justified? J Roy Soc Med 1990; 83: 25–28.

    Google Scholar 

  21. Hunt SM, McEwen J, McKenna SP. Measuring Health Status. London: Croom Helm, 1986.

    Google Scholar 

  22. Hunt SM, McKenna SP. The Nottingham Health Profile User's Manual. Manchester: Galen Research and Consultancy, 1991.

    Google Scholar 

  23. McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. New York: Oxford University Press, 1987.

    Google Scholar 

  24. Bowling A. Measuring Health. Buckingham: Open University Press, 1991.

    Google Scholar 

  25. McEwen J. The Nottingham Health Profile. In: Walker SR, Rosser RM, ed. Quality of Life Assessment: Key Issues in the 1990s. Dordrecht: Kluwer Academic Publishers, 1993: 111–130.

    Google Scholar 

  26. Kind P, Gudex C. The HMQ: Measuring Health Status in the Community. York: Centre for Health Economics, University of York, 1991; Discussion Paper 93.

    Google Scholar 

  27. Williams A. Applications in management. In: Teeling-Smith G, ed. Measuring Health: A Practical Approach. Chichester: Wiley, 1988: 225–243.

    Google Scholar 

  28. Whynes DK, Neilson AR. Convergent validity of two measures of the quality of life. Health Econ 1993; 2: 229–235.

    Google Scholar 

  29. Hunt SM. Subjective health indicators and health promotion. Health Promotion 1988; 3: 23–34.

    Google Scholar 

  30. Hunt SM, McKenna SP, McEwen J, et al. A quantitative approach to perceived health status: a validation study. J Epidemiol Commun Health 1980; 34: 281–286.

    Google Scholar 

  31. Devlin HB, Plant JA, Griffen M. Aftermath of surgery for ano-rectal cancer. Br Med J 1971; 3: 413–418.

    Google Scholar 

  32. DHSS Working Group (Sir Patrick Forrest-Chairman). Breast Cancer Screening: Report to the Health Ministers of England, Wales, Scotland and Northern Ireland. London: HMSO, 1986.

    Google Scholar 

  33. Standing Medical Advisory Committee Working Party (Chairman: Sir Eric Stroud). Blood Cholesterol Testing: The Cost-effectiveness of Opportunistic Cholesterol Testing. London: Department of Health, 1990.

    Google Scholar 

  34. De Haes JCJM, De Koning HJ, Van Oortmarssen GJ, et al. The impact of a breast cancer screening programme on quality-adjusted life-years. Int J Cancer 1991; 49: 538–544.

    Google Scholar 

  35. De Koning HJ, Van Ineveld BM, Van Oortmarssen GJ, et al. Breast cancer screening and cost-effectiveness: policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991; 49: 531–537.

    Google Scholar 

  36. Kind P, Carr-Hill R. The Nottingham Health profile: a useful tool for epidemiologists? Soc Sci Med 1987; 25: 905–910.

    Google Scholar 

  37. Walker SR, Rosser RM, ed. Quality of Life Assessment: Key Issues in the 1990s Dordrecht: Kluwer Academic Publishers, 1993.

    Google Scholar 

  38. Selby P. Measurement of the quality of life: the particular problems of cancer patients. In: Hopkins A, ed. Measures of the Quality of Life. London: Royal College of Physicians of London, 1992: 91–104.

    Google Scholar 

  39. Jonsson B. Assessment of quality of life in clinical diseases. Acta Paed Scand 1987; 337 (Supplement): 164–165.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Economics, University of Nottingham, NG7 2RD, Nottingham, UK

    D. K. Whynes

  2. Department of Surgery, University of Nottingham, NG7 2RD, Nottingham, UK

    A. R. Neilson, M. H. E. Robinson & J. D. Hardcastle

Authors
  1. D. K. Whynes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. R. Neilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. H. E. Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. D. Hardcastle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whynes, D.K., Neilson, A.R., Robinson, M.H.E. et al. Colorectal cancer screening and quality of life. Qual Life Res 3, 191–198 (1994). https://doi.org/10.1007/BF00435384

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00435384

Keywords

Search

Navigation